EPIC Ventures

EPIC Ventures is a venture capital firm founded in 1994 in Salt Lake City, Utah, originally established by Zions Bank. It invests in early-stage technology companies, backing entrepreneurs positioned to lead tomorrow's information economy, with nearly three decades of fund management experience. The firm partners closely with regional institutions, including ARUP Laboratories and, since September 2024, the University of Utah through "University of Utah Ventures, Powered by EPIC," a fund designed to commercialize university research leveraging the school's nearly $700 million in annual research funding. EPIC's sector focus spans edtech, fintech, healthcare, SaaS, biotech, and security, targeting pre-seed through Series A stages, primarily in the Mountain West though not exclusively. The firm manages over $170 million in assets, has made roughly 288 investments across 9 funds, and counts 60 portfolio exits, including 17 IPOs, such as Recursion Pharmaceuticals (NASDAQ: RXRX). EPIC's investment approach favors active involvement, typically seeking board representation in each of its investments, and draws on a network of over ten sector-specific venture partners with deep operating experience across SaaS, fintech, healthcare, and cybersecurity to support portfolio companies from seed through late-stage financing.